Close menu
- Home
- News
- Research
- Opinion
- Features
- Culture
- Careers
- Podcasts
- Webinars
-
Collections
- Back to parent navigation item
- Collections
- The future of energy storage
- AI and automation in chemistry
- Sustainable labs
- Research culture
- Coronavirus
- Nobel prize
-
Themed supplements
- Back to parent navigation item
- Themed supplements
- Problem solvers
- Inspiring science
- Up to the challenge
- Eureka moments
- Chemistry 4.0
- Forefront of pharma
- Collaborative chemistry
- Everyday chemistry
- Future of pharma
- Voices in chemistry
- Chemistry detectives
- Innovators
- Green and sustainable chemistry
- Health technology
- View all
- Partner collections
- Register
The diabetes drugs aiming to aid weight loss
By Anthony King2023-05-25T14:34:00
Source: © Sandy Huffaker/The Washington Post/Getty Images
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
A new class of drugs for obesity, which suppress appetite by mimicking human hormones, are being developed by the pharmaceutical industry in its latest effort to access the lucrative potential market for weight loss treatments.
- This website collects cookies to deliver a better user experience. See how this site uses cookies.
- This website collects cookies to deliver a better user experience. Do not sell my personal data.
- Este site coleta cookies para oferecer uma melhor experiência ao usuário. Veja como este site usa cookies.
Site powered by Webvision Cloud